Edap Tms S.A. shares rise 5.56% after-hours as European Equities Traded in the US as American.

Edap Tms S.A. rose 5.56% in after-hours trading, with the company being highlighted as a France-based developer of minimally invasive medical devices for urology. The company's focus on HIFU technology, a non-invasive treatment for prostate conditions, and its partnership with INSERM French public laboratory and international medical research institutions may have contributed to the positive sentiment.